Cite
Effect of Sodium-Glucose Cotransporter-2 Inhibitors versus Dipeptidyl Peptidase 4 Inhibitors on Cardiovascular Function in Patients with Type 2 Diabetes Mellitus and Coronary Artery Disease.
MLA
Lee, Sook Jung, et al. “Effect of Sodium-Glucose Cotransporter-2 Inhibitors versus Dipeptidyl Peptidase 4 Inhibitors on Cardiovascular Function in Patients with Type 2 Diabetes Mellitus and Coronary Artery Disease.” Journal of Obesity & Metabolic Syndrome, vol. 28, no. 4, Dec. 2019, pp. 254–61. EBSCOhost, https://doi.org/10.7570/jomes.2019.28.4.254.
APA
Lee, S. J., Lee, K. H., Oh, H. G., Seo, H. J., Jeong, S. J., & Kim, C. H. (2019). Effect of Sodium-Glucose Cotransporter-2 Inhibitors versus Dipeptidyl Peptidase 4 Inhibitors on Cardiovascular Function in Patients with Type 2 Diabetes Mellitus and Coronary Artery Disease. Journal of Obesity & Metabolic Syndrome, 28(4), 254–261. https://doi.org/10.7570/jomes.2019.28.4.254
Chicago
Lee, Sook Jung, Kook Hyung Lee, Hyun Geong Oh, Hye Ji Seo, Soo Jin Jeong, and Chong Hwa Kim. 2019. “Effect of Sodium-Glucose Cotransporter-2 Inhibitors versus Dipeptidyl Peptidase 4 Inhibitors on Cardiovascular Function in Patients with Type 2 Diabetes Mellitus and Coronary Artery Disease.” Journal of Obesity & Metabolic Syndrome 28 (4): 254–61. doi:10.7570/jomes.2019.28.4.254.